CompletedNot Applicable

Controlled Trial Comparing the Performance of 22 Gauge Versus 25 Gauge EUS-FNA Needles (FNA-22G-25G)

Denmark, Germany135 participantsStarted 2009-11

Plain-language summary

The aim of the study is to compare the performance characteristics of EUS-FNA 22 Gauge needle and EUS FNA 25 Gauge needle in terms of cellularity and diagnostic yield for diagnosis of various pathologies, including lymph nodes, pancreatic, luminal and other lesions outlined by EUS.

Who can participate

Age range18 Years – 85 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients referred for an EUS examination and EUS-FNA of a solid mass lesion adjacent to the upper GI tract * Well informed signed consent for EUS-guided FNA Exclusion Criteria: * Severe coagulopathy * Uncorrectable severe platelet dysfunction * Presence of large intervening vessels on color or power Doppler * Failure to provide informed consent

What they're measuring

Value of EUS-FNA 22 Gauge needle comparing with EUS-FNA 25 Gauge needle in terms of cellularity and diagnostic yield for diagnosis of various pathologies.

Timeframe: 6 months

Trial details

NCT IDNCT01016288

SponsorUniversity Hospital, Gentofte, Copenhagen

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2010-04

View on ClinicalTrials.gov More Mediastinal Tumours and Lymph Nodes trials